Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.

Pharmaceutical

Evotec

Craig Johnstone

Laetitia Rouxel

Cord Dohrmann

Hans-Ulrich Wolf

The Engineering and Software Development team at Evotec focuses on designing, developing, and maintaining software solutions that support and enhance drug discovery and development processes. This team ensures the integration of advanced software and IT systems to optimize research activities, streamline drug discovery workflows, and facilitate data analysis and management, ultimately supporting Evotec's goal of advancing innovative therapies.

Engineering and Software Development

Scientific Research & Development

Vice Presidents and Senior Vice Presidents

Project and Operations Management

Engineering and Software Development

About

Team members

Other teams at Evotec

Scientific Research & Development

Vice Presidents and Senior Vice Presidents

Project and Operations Management